MAT in 2026: What Medication-Assisted Treatment Is (and What It Isn't)
Buprenorphine, methadone, naltrexone — and the cultural fight that's kept millions from accessing them.
Body: [Structured as: What MAT is → The three medications compared → Evidence (~50% reduction in all-cause mortality for OUD, per multiple meta-analyses) → Who it’s for → Myths and stigma (including the “just trading one addiction for another” misconception) → How to access it in 2026, including the permanent telehealth rule. Written as a definitive reference.]
Sources Cited
- 01.A
- 02.B
Filed Under
MAT — BuprenorphineStigmaPeer-Reviewed Research
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Ketamine Got Respectable. It Didn't Get Safe.
Ketamine clinics went from fewer than 100 to well over 1,500 in a decade, DEA enforcement is finally catching up, and recreational misuse is climbing alongside it. What that means if you're in recovery and someone offers you ketamine therapy.
Treatment & RecoveryMethadone's Rules Got Looser. Too Many Clinics Haven't Let Go.
Federal rules loosened methadone take-home and counseling requirements in 2024. STAT News reporting shows many clinics and states are still applying the old, rigid practices.
Treatment & RecoveryThe Thing That Gets People Into Treatment Was Never the Syringe. It Was the Person Handing It Over.
Syringe service program participants are roughly five times more likely to enter treatment. The psychology behind that number is about trust, not paraphernalia — and it's what federal cuts actually put at risk.